NuVasive Preliminary 4Q17 and 2017 Revenue

NuVasive announced preliminary 4Q17 revenue of ~US $272.0MM, +0.3% vs. 4Q16, and full-year 2017 revenue of ~$1,030.0MM, +7% vs. 2016.

The company achieved the top-end of its full-year guidance that was revised in 3Q17 to reflect 3Q results, lingering effects from the hurricane in Puerto Rico and continued slow growth of U.S. procedure...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us